1. Dong, Xiaoying, Liu, Ting, Li, Zhizhao, Zhai, Yongzhen. 2023. Non-SMC condensin I complex subunit D2 (NCAPD2) reveals its prognostic and immunologic features in human cancers. In Aging, 15, 7237-7257. doi:10.18632/aging.204904. https://pubmed.ncbi.nlm.nih.gov/37498296/
2. Ge, Hao, Wang, Can, Zhao, Haoran, Liu, Ping, Yang, Bolin. . Targeting NCAPD2 as a Therapeutic Strategy for Crohn's Disease: Implications for Autophagy and Inflammation. In Inflammatory bowel diseases, 31, 178-188. doi:10.1093/ibd/izae211. https://pubmed.ncbi.nlm.nih.gov/39340820/
3. Zhang, Ping, Liu, Ling, Huang, Jinsha, Xiong, Nian, Wang, Tao. 2014. Non-SMC condensin I complex, subunit D2 gene polymorphisms are associated with Parkinson's disease: a Han Chinese study. In Genome, 57, 253-7. doi:10.1139/gen-2014-0032. https://pubmed.ncbi.nlm.nih.gov/25166511/
4. Wu, Peiling, Zhao, Lifang, Zhang, Hongyan, Liu, Xueqing, Jiang, Handong. 2024. NCAPD2 serves as a potential prognostic biomarker for lung adenocarcinoma and promotes cell proliferation, migration, invasion and cell cycle in vitro. In Oncology research, 32, 1439-1452. doi:10.32604/or.2024.047490. https://pubmed.ncbi.nlm.nih.gov/39220139/
5. Feng, Linyuan, Yang, Yang, Lin, Zhenhua, Jin, Aihua, Cui, Aili. 2024. NCPAD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancer. In Genes and environment : the official journal of the Japanese Environmental Mutagen Society, 46, 2. doi:10.1186/s41021-023-00291-4. https://pubmed.ncbi.nlm.nih.gov/38172945/
智鼠故事 
